Yeh Hsu-Hua, Ahuja Manmeet, Chiang Yi-Ming, Oakley C Elizabeth, Moore Shauna, Yoon Olivia, Hajovsky Heather, Bok Jin-Woo, Keller Nancy P, Wang Clay C C, Oakley Berl R
Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California , Los Angeles, California 90089, United States.
Department of Molecular Biosciences, University of Kansas , Lawrence, Kansas 66045, United States.
ACS Chem Biol. 2016 Aug 19;11(8):2275-84. doi: 10.1021/acschembio.6b00213. Epub 2016 Jun 21.
Fungal genome projects are revealing thousands of cryptic secondary metabolism (SM) biosynthetic gene clusters that encode pathways that potentially produce valuable compounds. Heterologous expression systems should allow these clusters to be expressed and their products obtained, but approaches are needed to identify the most valuable target clusters. The inp cluster of Aspergillus nidulans contains a gene, inpE, that encodes a proteasome subunit, leading us to hypothesize that the inp cluster produces a proteasome inhibitor and inpE confers resistance to this compound. Previous efforts to express this cluster have failed, but by sequentially replacing the promoters of the genes of the cluster with a regulatable promotor, we have expressed them successfully. Expression reveals that the product of the inp cluster is the proteasome inhibitor fellutamide B, and our data allow us to propose a biosynthetic pathway for the compound. By deleting inpE and activating expression of the inp cluster, we demonstrate that inpE is required for resistance to internally produced fellutamide B. These data provide experimental validation for the hypothesis that some fungal SM clusters contain genes that encode resistant forms of the enzymes targeted by the compound produced by the cluster.
真菌基因组计划正在揭示数以千计的隐秘次级代谢(SM)生物合成基因簇,这些基因簇编码的途径有可能产生有价值的化合物。异源表达系统应能使这些基因簇得以表达并获得其产物,但需要一些方法来确定最有价值的目标基因簇。构巢曲霉的inp基因簇包含一个基因inpE,该基因编码一种蛋白酶体亚基,这使我们推测inp基因簇产生一种蛋白酶体抑制剂,且inpE赋予对该化合物的抗性。此前表达该基因簇的尝试均告失败,但通过用一个可调控的启动子依次替换该基因簇中各基因的启动子,我们成功实现了它们的表达。表达结果显示,inp基因簇的产物是蛋白酶体抑制剂费鲁他胺B,并且我们的数据使我们能够提出该化合物的生物合成途径。通过删除inpE并激活inp基因簇的表达,我们证明inpE是对内源性产生的费鲁他胺B产生抗性所必需的。这些数据为以下假设提供了实验验证:一些真菌SM基因簇包含编码对该基因簇所产生化合物的靶向酶具有抗性形式的酶的基因。